Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view, European Journal of Medical Research
Treatment of covid-19 with ivermectin + fluvoxamine combination - Medical Update Online
Ivermectin: Cochrane's most talked about review so far, ever. Why?
Ivermectin: why a potential COVID treatment isn't recommended for use
Biologics, Free Full-Text
Study claiming that ivermectin reduces COVID-19 mortality by 92% has important methodological problems - Health Feedback
COVID-19 treatments: WHO issues updated guidelines
Biologics, Free Full-Text
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial, BMC Infectious Diseases
Group of physicians combats misinformation as unproven COVID-19 treatments continue to be prescribed - ABC News
COVID-19, News
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial - ScienceDirect
PDF) Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial
Viruses, Free Full-Text